Text Size
10 studies found for:    Provectus

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Randomized Study of PH-10 for Psoriasis
Condition: Psoriasis
Interventions: Drug: PH-10 (0.002% Rose Bengal);   Drug: PH-10 (0.005% Rose Bengal);   Drug: PH-10 (0.01% Rose Bengal);   Drug: Vehicle
2 Completed Intralesional PV-10 Chemoablation of Metastatic Melanoma
Condition: Melanoma
Intervention: Drug: PV-10 (rose bengal disodium, 10%)
3 Recruiting A Study to Assess PV-10 Chemoablation of Cancer of the Liver
Conditions: Cancer Metastatic to the Liver;   Recurrent Hepatocellular Carcinoma
Intervention: Drug: PV-10 (10% rose bengal disodium)
4 Completed An Efficacy and Safety Study of PH-10 Aqueous Hydrogel for the Treatment of Plaque Psoriasis
Condition: Psoriasis
Intervention: Drug: PH-10 (0.001% Rose Bengal)
5 Completed PV-10 Chemoablation of Recurrent Breast Carcinoma
Condition: Breast Cancer
Intervention: Drug: PV-10 (rose bengal disodium 10%)
6 Completed A Phase 2 Study of PH-10 for the Treatment of Atopic Dermatitis
Condition: Atopic Dermatitis
Intervention: Drug: PH-10
7 Terminated Topical PH-10 Aqueous Hydrogel and Photodynamic Therapy for Psoriasis
Condition: Plaque Psoriasis
Interventions: Drug: PH-10 (rose bengal disodium 0.001%);   Drug: Control
8 Completed Phase 2 Study of Intralesional PV-10 for Metastatic Melanoma
Condition: Melanoma
Intervention: Drug: PV-10 (10% rose bengal disodium)
9 Available Expanded Access Protocol for PV-10 for Cutaneous or Subcutaneous Tumors
Conditions: Cutaneous or Subcutaneous Tumors Where There is no Comparable or Satisfactory;   Approved Alternative Therapy
Intervention: Drug: PV-10 (10% rose bengal disodium)
10 Recruiting Detection of Immune Cell Infiltration Into Melanomas Treated by PV-10, a Feasibility Study
Condition: Melanoma
Interventions: Drug: PV-10;   Procedure: Surgery
To Top

† Indicates status has not been verified in more than two years